Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status

By Nathan P.   Sharma A.   Lorigan P.  

Annals of Oncology, Vol. 24, Iss. 6, 2013-06 ,pp. : 1712-1713

Oxford University Press

Access to resources Recommend Favorite

2010 TNM Staging System for Cutaneous Melanoma…and Beyond

By Gershenwald Jeffrey  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1475-1477

Springer Publishing Company

Access to resources Recommend Favorite

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

By Tímár József   Győrffy Balázs   Rásó Erzsébet  

Clinical and Experimental Metastasis, Vol. 27, Iss. 6, 2010-08 ,pp. : 371-387

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic Patterns, Clinical Outcome, and Malignant Phenotype in Malignant Cutaneous Melanoma

By Cohn-Cedermark Gabriella   Månsson-Brahme Eva   Rutqvist Lars Erik   Larsson Olle   Singnomklao Toom   Ringborg Ulrik  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 549-558

Informa Healthcare

Access to resources Recommend Favorite